RxDoctor Payments Data

Drew Moss, MD

Family Medicine · Fort Meade, SDNPI 1003234097

Payments from drug & device makers

$271in general payments, 2019–2025

Across 18 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$171
  • Boehringer Ingelheim$50
  • Radius Health, Inc.$14
  • Astellas Pharma US Inc$13
  • Lilly USA, LLC$12
  • Sanofi-aventis U.S. LLC$11

What the payments were for

  • Food & beverage$271100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$271 in reported general payments places this provider in the 55th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$87,470
Medicare patients
463
Services billed
1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban80$95,882
JardianceEmpagliflozin89$90,531
MounjaroTirzepatide43$52,577
XareltoRivaroxaban32$45,744
Trijardy XrEmpaglifloz/Linaglip/Metformin26$33,282
OzempicSemaglutide25$32,985
RybelsusSemaglutide12$20,467
Xultophy 100-3.6Insulin Degludec/Liraglutide15$19,291
EntrestoSacubitril/Valsartan15$18,890
JanuviaSitagliptin Phosphate12$16,160
FarxigaDapagliflozin Propanediol15$14,781
Stiolto RespimatTiotropium Br/Olodaterol Hcl30$14,507
Tresiba Flextouch U-100Insulin Degludec21$12,928
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$5,690
Atorvastatin Calcium559$5,484

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Trijardy Xr, Stiolto Respimat$50$138,321145 claims
Lilly USA, LLCMounjaro$12$52,57743 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Fort Meade

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →